Sevuparin/DF02
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sevuparin/DF02, covering 2014-08-19 to 2014-08-19. Get the full timeline:
Most recent: Clinical Trial Update: Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria [Phase 1, Phase 2]